4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001250853-13-000106
$SLSCIK 0001390478operating
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 12:33 PM ET
Size
5.0 KB
Accession
0001250853-13-000106
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock
2013-10-11+7,349→ 504,009 total
Footnotes (1)
- [F1]The shares acquired were issued for the account of the reporting person at a value of $2.06 per share in payment of contingent value rights held by the reporting person.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 12:33 PM ET
- Size
- 5.0 KB